|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 19/06 | |
| A61K 31/7072 | |||
| A61P 31/12 | |||
| C07H 19/073 |
| (11) | Number of the document | 1534727 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03767281.3 |
| Date of filing the European patent application | 2003-08-06 | |
| (97) | Date of publication of the European application | 2005-06-01 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2003/024987 |
| Date | 2003-08-06 |
| (87) | Number | WO 2004/012687 |
| Date | 2004-02-12 |
| (30) | Number | Date | Country code |
| 401318 P | 2002-08-06 | US |
| (72) |
STORER, Richard, GB
JONAITIS, David, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS OF CRYSTALLINE BETA-L-2`-DEOXYTHYMIDINE |
| PHARMACEUTICAL COMPOSITIONS OF CRYSTALLINE BETA-L-2`-DEOXYTHYMIDINE |